Drug Shortage Report for TEVA-METHYLPHENIDATE ER-C

Last updated on 2020-01-21 History
Report ID 30691
Drug Identification Number 02315092
Brand name TEVA-METHYLPHENIDATE ER-C
Common or Proper name METHYLPHENIDATE
Company Name TEVA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 54MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-01-30
Actual start date 2018-01-30
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-21
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-01-21 French Compare
v10 2020-01-21 English Compare
v9 2018-10-11 French Compare
v8 2018-10-11 English Compare
v7 2018-05-30 French Compare
v6 2018-05-30 English Compare
v5 2018-03-13 French Compare
v4 2018-03-13 English Compare
v3 2018-01-31 English Compare
v2 2017-11-24 French Compare
v1 2017-11-24 English Compare